Chemoinformaics analysis of S-propyl-L-cysteine sulfoxide
| Molecular Weight | 179.241 | nRot | 5 |
| Heavy Atom Molecular Weight | 166.137 | nRig | 1 |
| Exact Molecular Weight | 179.062 | nRing | 0 |
| Solubility: LogS | -0.934 | nHRing | 0 |
| Solubility: LogP | -2.618 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 25.0943 |
| nHD | 2 | BPOL | 17.8977 |
| QED | 0.56 |
| Synth | 4.712 |
| Natural Product Likeliness | 0.608 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.573 |
| HIA | 0.01 |
| CACO-2 | -5.593 |
| MDCK | 0.000444775 |
| BBB | 0.497 |
| PPB | 0.186165 |
| VDSS | 0.467 |
| FU | 0.800383 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.067 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.497 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.191 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.021 |
| CL | 6.391 |
| T12 | 0.775 |
| hERG | 0.019 |
| Ames | 0.315 |
| ROA | 0.348 |
| SkinSen | 0.137 |
| Carcinogencity | 0.819 |
| EI | 0.093 |
| Respiratory | 0.283 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.931082 |